. 2012 Jun 18;80(4):789–823. doi: 10.3797/scipharm.1204-27
© Azam and Suresh; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 19.
Analogues of MBT that have shown the CCR3 receptor antagonist property